Neural tube defect
ORPHA:3388Category
Эпидемиология23
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 6-9 / 10 000 | 55 | United States | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 91.05 | Europe | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 88.75 | Belgium | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 76.8 | Austria | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 74.7 | Czech Republic | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 47.9 | Croatia | Value and class |
| Prevalence at birth | >1 / 1000 | 109.6 | Denmark | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 86.7 | Finland | Value and class |
| Prevalence at birth | >1 / 1000 | 120.2 | France | Value and class |
| Prevalence at birth | >1 / 1000 | 138.25 | Germany | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 67.2 | Hungary | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 87.4 | Ireland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 54.65 | Italy | Value and class |
| Prevalence at birth | >1 / 1000 | 109.5 | Malta | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 84.2 | Netherlands | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 92.7 | Norway | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 92.5 | Poland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 47.3 | Portugal | Value and class |
| Prevalence at birth | 6-9 / 10 000 | 98.5 | Spain | Value and class |
| Prevalence at birth | >1 / 1000 | 101.7 | Switzerland | Value and class |
| Prevalence at birth | >1 / 1000 | 115.5 | United Kingdom | Value and class |
| Prevalence at birth | >1 / 1000 | 1387 | China | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 31 | Brazil | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)